Emerging drug therapies for preventing spontaneous preterm labor and preterm birth

Bibliography

• MAGOWAN BA, BAIN M, JUSZCZAK E, MCINNENY K: Neonatal mortality amongst Scottish preterm singleton births (1985 – 1994). BJOG (1998) 105:1005-1010.
   Web of Science ®Google Scholar
• WOODS NS, MARLOW N, COSTELOE K, GIBSON AT, WILKINSIN AR: Neurologic and development disability after extremely preterm birth. Epicure Study Group. N. Engl. J. Med. (2000) 343:378-384.
   PubMed Web of Science ®Google Scholar
• LETTIERI L, VINTZILEOS AM, RODIS JF, ALBINI SM, SALAFIA CM: Does “idiopathic” preterm labour resulting in preterm birth exist? Am. J. Obstet. Gynecol. (1993) 168:1480-1485.
   PubMed Web of Science ®Google Scholar
• LAMONT RF: Infection in preterm labour. In: Infection and Pregnancy. Proceedings of the 40th Study Group of the Royal College of Obstetricians and Gynaecologists. Maclean A, Regan L, Carrington D (Eds), RCOG Press, London, UK (2001):305-317.
   Google Scholar
• HOESLI I, TERCANLI S, HOLZGREVE W: Cervical length assessment by ultrasound as a predictor of preterm labour – is there a role for routine screening? BJOG (2003) 110(Suppl. 20):61-65.
   PubMed Web of Science ®Google Scholar
• LEITICH H, KAIDER A: Fetal fibronectin – how useful is it in the prediction of preterm birth? BJOG (2003) 110(Suppl. 20):66-70.
   PubMed Web of Science ®Google Scholar
• VILLAR J, EZCURRA EJ, GURTNER DE LA FUENTA V, CAMPODONICA L: Preterm delivery syndrome: the unmet need. In: New Perspectives for the Effective Treatment of Preterm Labour – an International Consensus. Keirse MJ (Ed.), Research and Clinical Forums, Wells Medical, Tunbridge Wells, UK (1994) 16:9-38.
   Google Scholar
• FINNSTROM O, OLAUSSEN PO, SEDIN G et al.: The Swedish National Perspectives Study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to the level of care. Acta Paediatr. (1997) 86:503-511.
   PubMed Web of Science ®Google Scholar
• KIERSE MJ: New perspectives for the effective treatment of preterm labor. Am. J. Obstet. Gynecol. (1995) 173:618-628.
   PubMed Web of Science ®Google Scholar
• PETROU S: Economic consequences of preterm birth and low birthweight. BJOG (2003) 110(Suppl. 20):17-23.
   PubMed Web of Science ®Google Scholar
• NATHANIELSZ PW: Control of length of gestation: lessons from animals. In: Preterm Birth. Proceedings of the 46th Study Group of the Royal College of Obstetricians and Gynaecologists. Critchley H, Bennett P, Thornton S (Eds), RCOG Press, London, UK (2004):3-12.
   Google Scholar
• SMITH R, MESIANO S, NICHOLSON R et al.: Control of length of gestation: lessons for women. In: Preterm Birth. Proceedings of the 46th Study Group of the Royal College of Obstetricians and Gynaecologists. Critchley H, Bennett P, Thornton S (Eds), RCOG Press, London, UK (2004):13-27.
   Google Scholar
• ROMERO R, ESPINOZA J, MAZOR M, TINNAKORN C: The preterm parturition syndrome. In: Preterm Birth. Proceedings of the 46th Study Group of the Royal College of Obstetricians and Gynaecologists. Critchley H, Bennett P, Thornton S (Eds), RCOG Press, London, UK (2004):28-60.
   Google Scholar
• KEIRSE MJ: Progestogen administration in pregnancy may prevent preterm delivery. BJOG (1990) 97:149-154.
   Web of Science ®Google Scholar
• MEIS PJ, KLEBANOFF M, THOM E et al.: Prevention of recurrent preterm delivery by 17 α-hydroxy progesterone caproate. N. Engl. J. Med. (2003) 348:2379-2385.
   PubMed Web of Science ®Google Scholar
• DA FONSECA EB, BITTAR RE, CARVALHO MH, ZUGAIB M: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomised placebo controlled double blind study. Am. J. Obstet. Gynecol. (2003) 188:419-424.
   PubMed Web of Science ®Google Scholar
• CHANRACHAL B, BROUGHTON-PIPKIN F, WARREN AY et al.: Progesterone enhances the tocolytic effect of ritodrine in isolated pregnant human myometrium. Am. J. Obstet. Gynecol. (2005) 19q2:458-463.
   Google Scholar
• SANCHEZ-RAMOS L, KAUNITZ AM, DELKE I: Progestational agents to prevent preterm birth: a meta-analysis of randomised controlled trials. Obstet. Gynecol. (2005) 105:273-279.
   PubMed Web of Science ®Google Scholar
• DODD JD, CROWTHER CA, CINCOTTA R, FLENADY V, ROBINSON JS: Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. (2005) 84:526-533.
   PubMed Web of Science ®Google Scholar
• LAMONT RF, FISK N: The role of infection in the pathogenesis of preterm labour. In: Progress in Obstetrics and Gynaecology. Studd JWW (Ed.), Churchill Livingstone, London, UK (1993) 10:135-158.
   Google Scholar
• KLEBANOFF M, SEARLE K: The role of inflammation in preterm birth – focus on periodontitis. BJOG (2006) 113(Suppl. 3):43-45.
   PubMed Web of Science ®Google Scholar
• OLIVER R, LAMONT RF: The role of cytokines in spontaneous preterm labour and preterm birth. In: Progress in Obstetrics and Gynaecology. Studd JWW (Ed.), Elsevier, London, UK (2004) 16:83-106.
   Google Scholar
• ROMERO R, GOMEZ R, MAZOR M, GHEZZI F, YOON BH: The preterm labour syndrome. In: Preterm Labor. Elder MG, Lamont RF, Romero R (Eds), Churchill Livingstone, New York, USA (1997):29-49.
   Google Scholar
• YOON BH, ROMERO R, YANK SH et al.: Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leucomalacia. Am. J. Obstet. Gynecol. (1996) 174:1433-1440.
   PubMed Web of Science ®Google Scholar
• YOON BH, ROMERO R, JUN JK et al.: Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1β, and interleukin 8) and the risk for the development of bronchopulmonary dysplasia. Am. J. Obstet. Gynecol. (1997) 177:825-830.
   PubMed Web of Science ®Google Scholar
• YOON BH, ROMERO R, PARK JS et al.: Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am. J. Obstet. Gynecol. (2000) 182:675-681.
   PubMed Web of Science ®Google Scholar
• LAMONT RF: Bacterial vaginosis. In: Preterm Birth. Proceedings of the 46th Study Group of the Royal College of Obstetricians and Gynaecologists. Critchley H, Thornton S, Bennett PR (Eds), RCOG Press, London, UK (2004):163-180.
   Google Scholar
• HAY PE, LAMONT RF, TAYLOR-ROBINSON D, MORGAN DJ, ISON C, PEARSON J: Abnormal bacterial colonisation of the genital tract as a marker for subsequent preterm delivery and late miscarriage. Br. Med. J. (1994) 308:295-298.
   PubMed Web of Science ®Google Scholar
• SALING E, SCHREIBER M, AL-TAIE T: A simple, efficient and inexpensive program for preventing prematurity. J. Perinat. Med. (2001) 29:199-211.
   PubMed Web of Science ®Google Scholar
• MCDONALD HM, BROCKLEHURST P, PARSONS J, VIGNESWARAN: Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. (2003) 2:CD000262.
   Google Scholar
• LAMONT RF: Can antibiotics prevent preterm birth – the pro and con debate? BJOG (2005) 112(Suppl. 1):67-73.
   PubMed Web of Science ®Google Scholar
• LAMONT RF, DUNCAN SLB, MANDAL D, BASSETT P: Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet. Gynecol. (2003) 101:516-522.
   PubMed Web of Science ®Google Scholar
• UGWUMADU A, MANYONDA I, REID F, HAY P: Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised trial. Lancet (2003) 361:983-988.
   PubMed Web of Science ®Google Scholar
• KISS H, PETRICEVIC L, HUSSLEIN P: Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br. Med. J. (2004) 329:371.
   PubMed Web of Science ®Google Scholar
• LARSSON P, FÅHRAEUS L, CARLSSON B, JAKOBSSON T, FORSUM U: Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG (2006) 113:629-637.
   PubMed Web of Science ®Google Scholar
• LAMONT RF, JONES BM, MANDAL D, HAY PE, SHEEHAN M: The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Inf. Dis. Obstet. Gynecol. (2003) 11:181-189.
   PubMedGoogle Scholar
• SHENNAN A, CRAWSHAW S, BRILEY A et al.: A randomised controlled trial of metrondiazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. BJOG (2006) 113:65-74.
   PubMed Web of Science ®Google Scholar
• LAMONT RF, DRAVOGIC B: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. BJOG (2006) 113:850-851.
   PubMed Web of Science ®Google Scholar
• SEO K, MCGREGOR JA, FRENCH JI: Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet. Gynecol. (1992) 79:75-80.
   PubMed Web of Science ®Google Scholar
• ROSENSTEIN IJ, MORGAN DJ, LAMONT RF et al.: Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Inf. Dis. Obstet. Gynecol. (2000) 8:158-165.
   PubMedGoogle Scholar
• NEGGERS Y, GOLDENBERG RL: Some thoughts on body mass index, micronutrient intakes and pregnancy outcome. J. Nutr. (2003) 133(Suppl. 5S):S1737-S1740.
   PubMed Web of Science ®Google Scholar
• HENDLER I, GOLDENBERG RL, MERCER B et al.: The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birth. Am. J. Obstet. Gynecol. (2005) 192:882-886.
   PubMed Web of Science ®Google Scholar
• KRAMER MS, MCCLEAN FH, EASON EL, USHER RH: Maternal nutrition and spontaneous preterm birth. Am. J. Epidemiol. (1992) 136:574-583.
   PubMed Web of Science ®Google Scholar
• SIEGA-RIZ AM, ADAIR LS, HOBEL CJ: Maternal underweight status and inadequate rate of weight gain during the third trimester of pregnancy increases the risk of preterm delivery. J. Nutr. (1996) 126:146-153.
   PubMed Web of Science ®Google Scholar
• TAMURA T, GOLDENBERG RL, JOHNSTON KE, CHAPMAN VR: Relationship between pre-pregnancy BMI and plasma zinc concentrations in early pregnancy. Br. J. Nutr. (2004) 91:773-777.
   PubMed Web of Science ®Google Scholar
• VAHRATIAN A, SIEGA-RIZ AM, SAVITZ DA, THORP JM: Multivitamin use and the risk of preterm birth. Am. J. Epidemiol. (2004) 160(9):886-892.
   PubMed Web of Science ®Google Scholar
• CROWTHER CA, HILLER JE, PRIDMORE B et al.: Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, pre-eclampsia and preterm birth: an Australian randomized trial. FRACOG and the ACT Study Group. Aust. NZ J. Obstet. Gynaecol. (1999) 39(1):12-18.
   PubMed Web of Science ®Google Scholar
• LUKE B: The evidence linking maternal nutrition and prematurity. J. Perinat. Med. (2005) 33:500-505.
   PubMed Web of Science ®Google Scholar
• SMITS LJM, ESSED GGM: Short interpregnancy intervals and unfavourable pregnancy outcome: role of folate depletion. Lancet (2001) 358:2074-2077.
   PubMed Web of Science ®Google Scholar
• KING JC: The risk of maternal nutritional depletion and poor outcomes increases in early or closely spaced pregnancies. J. Nutr. (2003) 133(S5):S1732-S1736.
   PubMed Web of Science ®Google Scholar
• SIEGA-RIZ A, SAVITZ DA, ZEISEL SH, THORP JM, HERRING A: Second trimester folate status and preterm birth. Am. J. Obstet. Gynecol. (2004) 191:1851-1857.
   PubMed Web of Science ®Google Scholar
• JOHNSON WG, SCHOLL TO, SPYCHALA JR, BUYSKE S, STENROOS ES, CHEN X: Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor preterm delivery. Am. J. Clin. Nutr. (2005) 81:664-668.
   PubMed Web of Science ®Google Scholar
• FACCHINETTI F, FAZZIO, VENTURINI P: Polyunsaturated fatty acids and risk of preterm delivery. Eur. Rev. Med. Pharmacol. Sci. (2005) 9:41-48.
   PubMedGoogle Scholar
• SIMOPOULOS AP: Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. (1991) 54:438-463.
   PubMed Web of Science ®Google Scholar
• OLSEN SF, SECKER NJ: A possible preventive effect of low dose fish oil on early delivery and pre-eclampsia: indications from a 50 year old controlled trial. Br. J. Nutr. (1990) 64:599-609.
   PubMed Web of Science ®Google Scholar
• OLSEN SF, SECHER NJ, TABOR A, WEBER T, WALKER JJ, GLUUD C: Randomised clinical trials of fish oil supplementation in high risk pregnancies. BJOG (2000) 107:382-395.
   PubMed Web of Science ®Google Scholar
• OLSEN SF, SORENSEN JD, SECHER NJ et al.: Randomised control trial of the effect of fish-oil supplementation on pregnancy duration. Lancet (1992) 339:1003-1007.
   PubMed Web of Science ®Google Scholar
• OLSEN SF, SECHER NJ: Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. Br. Med. J. (2002) 324:447-450.
   PubMed Web of Science ®Google Scholar
• SMUTS CM, HUANG M, MUNDY D, PLASSE T, MAJOR S, CARLSON SE: A randomised trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet. Gynecol. (2003) 101(3):469-479.
   PubMed Web of Science ®Google Scholar
• OLSEN SF, SECHER N.J, BJORNSSON S, WEBER T, ATKE A: The potential benefits of using fish oil in relation to preterm labor: the case for a randomised controlled trial? Acta Obstet. Gynecol. Scand. (2003) 82:978-982.
   PubMed Web of Science ®Google Scholar
• KNUDSEN VK, HANSEN HS, OSTERDAL ML, MIKKELSEN TB, MU H, OLSEN SF: Fish oil in various doses or flax oil in pregnancy and timing of delivery: a randomised control trial. BJOG (2006) 113:536-543.
   PubMed Web of Science ®Google Scholar
• LAMONT RF: Setting up a preterm prevention clinic: a practical guide. BJOG (2006) 113(Suppl. 3):86-92.
   Google Scholar
• ROMERO R, ESPINOZA J, GOTSCH F et al.: The use of high dimensional biology (genomics, transcriptomics, proteomics and metabolomics) to understand the preterm parturition syndrome. BJOG (2006) 113(Suppl. 3):118-135.
   PubMed Web of Science ®Google Scholar